News | Radiation Therapy | May 15, 2025

As part of the investment, the company will relocate the manufacturing operations of Varian, a Siemens Healthineers company, from Mexico to California, to improve its ability to respond to the demand for its radiotherapy solutions and reduce the complexity of its global supply chain.

Siemens Healthineers to Invest $150 Million in New, Expanded U.S. Facilities

May 14, 2025 — Siemens Healthineers is investing $150 million in new projects to expand production, create jobs and better serve customers in the United States, its largest market globally.

The new investments come on top of the $900 million Siemens Healthineers spends on R&D in the U.S. annually and more than $1 billion invested through facilities expansion, acquisitions and strategic partnerships in the U.S. since 2019.

The latest investments include:

  • Bringing manufacturing back to the U.S.: relocation of manufacturing operations for Varian, a Siemens Healthineers company, from Baja, Mexico to Palo Alto, CA, adding approximately 50 new manufacturing jobs. The change will reduce the complexity of our global supply chain and improve our ability to respond to demand for Varian’s radiotherapy solutions.
  • Strengthening supply-chain resilience: opening mega supply depots in Dayton, NJ and Manteca, CA to increase availability of parts by nearly a third and offer unprecedented delivery flexibility to customers.
  • Helping healthcare providers digitize and transform care delivery: construction of a 60,000 square foot Siemens Healthineers Experience Center in Charlotte, NC. The center is part of The Pearl, Charlotte’s research and innovation district.

"North Carolina is home to some of the leading research and innovation firms in the nation,” said North Carolina Governor Josh Stein. “Siemens Healthineers’ $141 million investment in the Pearl in Charlotte is the latest in a long line of companies that see the value of our well-trained workforce thanks to advanced health education programs in our state.”

Added John Kowal, president and head of Siemens Healthineers in the Americas: “Our significant U.S. employee base and broad portfolio of innovations are making vital contributions to the American healthcare system. With these new investments we’re further demonstrating our long-term commitment and desire to grow along with the American economy.”


Related Content

News | Radiopharmaceuticals and Tracers

Jan. 29, 2026 — The American Society for Radiation Oncology (ASTRO) has launched a national program creating Authorized ...

Time January 30, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Radiology Imaging

Jan. 21, 2026 — Cathpax, a spin-off of the Lemer Pax group that designs, develops and commercializes team-wide, full ...

Time January 22, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Radiopharmaceuticals and Tracers

Dec. 11, 2025 — Telix Pharmaceuticals Ltd. has announced a strategic clinical collaboration with Varian, a Siemens ...

Time December 11, 2025
arrow
News | FDA

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
News | Interventional Radiology

Nov. 12, 2025 — On Nov. 11, Huntsman Cancer Institute at the University of Utah (the U) opened its first specialized ...

Time November 13, 2025
arrow
News | Radiology Business

Nov. 12, 2025 — Siemens has announced plans to deconsolidate its remaining stake in Siemens Healthineers (currently ...

Time November 13, 2025
arrow
News | Radiopharmaceuticals and Tracers

Nov. 11, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released a position paper outlining ...

Time November 12, 2025
arrow
News | Prostate Cancer

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Subscribe Now